Literature DB >> 3138806

Norfloxacin vs best parenteral therapy in treatment of moderate to serious, multiply-resistant, nosocomial urinary tract infections: a pharmacoeconomic analysis.

R T Scheife1, C E Cox, R E McCabe, C Grad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3138806

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  5 in total

Review 1.  Treatment of urinary tract infection. Clinical and economic considerations.

Authors:  R J Plumridge; C L Golledge
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

Review 2.  Current concepts in the treatment of genitourinary tract disorders in the older individual.

Authors:  A Atala; M Amin
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

3.  Economic evaluation of oral ofloxacin versus standard parenteral therapy in the treatment of pneumonia.

Authors:  J Menzin; D M Huse; R Richner; G Oster
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

4.  Cost-effectiveness of abbreviating the duration of intravenous antibacterial therapy with oral fluoroquinolones.

Authors:  K M Jensen; J A Paladino
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

Review 5.  Modes of administration of antibiotics for symptomatic severe urinary tract infections.

Authors:  A Pohl
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.